206 related articles for article (PubMed ID: 17968018)
1. A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors.
Epping MT; Wang L; Plumb JA; Lieb M; Gronemeyer H; Brown R; Bernards R
Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17777-82. PubMed ID: 17968018
[TBL] [Abstract][Full Text] [Related]
2. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
3. UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid.
Epping MT; Meijer LA; Bos JL; Bernards R
Mol Cancer Res; 2009 Nov; 7(11):1861-70. PubMed ID: 19843631
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors regulate retinoic acid receptor beta expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms.
De los Santos M; Zambrano A; Sánchez-Pacheco A; Aranda A
Mol Endocrinol; 2007 Oct; 21(10):2416-26. PubMed ID: 17622583
[TBL] [Abstract][Full Text] [Related]
5. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.
Epping MT; Wang L; Edel MJ; Carlée L; Hernandez M; Bernards R
Cell; 2005 Sep; 122(6):835-47. PubMed ID: 16179254
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells.
De los Santos M; Zambrano A; Aranda A
Mol Cancer Ther; 2007 Apr; 6(4):1425-32. PubMed ID: 17431121
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
[TBL] [Abstract][Full Text] [Related]
8. Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid.
Somenzi G; Sala G; Rossetti S; Ren M; Ghidoni R; Sacchi N
PLoS One; 2007 Sep; 2(9):e836. PubMed ID: 17786207
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis.
Hatoum A; El-Sabban ME; Khoury J; Yuspa SH; Darwiche N
Carcinogenesis; 2001 Dec; 22(12):1955-63. PubMed ID: 11751425
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.
He LZ; Tolentino T; Grayson P; Zhong S; Warrell RP; Rifkind RA; Marks PA; Richon VM; Pandolfi PP
J Clin Invest; 2001 Nov; 108(9):1321-30. PubMed ID: 11696577
[TBL] [Abstract][Full Text] [Related]
11. Unique anti-activator protein-1 activity of retinoic acid receptor beta.
Lin F; Xiao D; Kolluri SK; Zhang X
Cancer Res; 2000 Jun; 60(12):3271-80. PubMed ID: 10866321
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
13. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
[TBL] [Abstract][Full Text] [Related]
14. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.
Xu XC; Liu X; Tahara E; Lippman SM; Lotan R
Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells.
Farias EF; Arapshian A; Bleiweiss IJ; Waxman S; Zelent A; Mira-Y-Lopez R
Cell Growth Differ; 2002 Aug; 13(8):335-41. PubMed ID: 12193472
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid and histone deacetylase inhibitor BML-210 inhibit proliferation of human cervical cancer HeLa cells.
Borutinskaite VV; Navakauskiene R; Magnusson KE
Ann N Y Acad Sci; 2006 Dec; 1091():346-55. PubMed ID: 17341627
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor function of a dominant negative retinoic acid receptor mutant.
Crowe DL; Osaseri UE; Shuler CF
Mol Carcinog; 1998 May; 22(1):26-33. PubMed ID: 9609098
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid signaling pathways.
Ghyselinck NB; Duester G
Development; 2019 Jul; 146(13):. PubMed ID: 31273085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
